首页> 外文期刊>Indian journal of cancer. >Correlation between the preoperative serum prostate specific antigen, Gleason score, and clinical staging with pathological outcome following robot-assisted radical prostatectomy: An Indian experience
【24h】

Correlation between the preoperative serum prostate specific antigen, Gleason score, and clinical staging with pathological outcome following robot-assisted radical prostatectomy: An Indian experience

机译:机器人辅助根治性前列腺切除术后术前血清前列腺特异性抗原,格里森评分和临床分期与病理结果之间的相关性:印度的经验

获取原文
获取原文并翻译 | 示例
       

摘要

Objectives: To correlate the preoperative serum prostate specific antigen (PSA), Gleason score, and clinical staging with pathological outcome following robot-assisted radical prostatectomy (RARP) in Indian men with clinically localized cancer prostate. Materials and Methods: A prospective study analysis was done for 166 consecutive patients of prostate cancer who underwent RARP at our center from June 2006 to October 2009. Preoperative workup included serum PSA, biopsy Gleason score, and clinical staging. The preoperative parameters were correlated with final Gleason score, capsular penetration, seminal vesicle involvement, and lymph node status on final histopathology. Results: The mean age was 64 years (range: 50-76 years) with mean and median PSA of 17.98 ng/ml (range: 0.3-68.3 ng/ml) and 12.1 ng/ml, respectively. With increase in preoperative Gleason score, chance of organ confinement decreases (P=0.002) and capsular penetration increases (P=0.004) linearly. With increasing serum PSA, there is linear decrease in trend of organ-confined disease (P=0.03) and increased chances of seminal vesicle involvement (P=0.02). Patients with higher clinical stage have less probability of localized disease (P=0.007) and more chances of capsular penetration (P=0.04) and seminal vesicle involvement (P=0.004). Conclusion: Our data suggest that patients with higher preoperative serum PSA, Gleason score, and clinical stage have more chances of advanced pathological stage following RARP.
机译:目的:将印度裔男性前列腺癌患者的机器人辅助根治性前列腺切除术(RARP)的术前血清前列腺特异性抗原(PSA),格里森评分和临床分期与病理结果相关联。材料与方法:对2006年6月至2009年10月在我们中心接受RARP治疗的166例前列腺癌患者进行了前瞻性研究分析。术前检查包括血清PSA,活检格里森评分和临床分期。术前参数与最终的Gleason评分,囊的渗透,精囊的受累以及最终的病理组织学状态相关。结果:平均年龄为64岁(范围:50-76岁),平均PSA和中值PSA分别为17.98 ng / ml(范围:0.3-68.3 ng / ml)和12.1 ng / ml。随着术前Gleason评分的增加,器官限制的机会呈线性下降(P = 0.002),荚膜穿透率呈线性增加(P = 0.004)。随着血清PSA的增加,器官限制疾病的趋势呈线性下降(P = 0.03),精囊受累机会增加(P = 0.02)。具有较高临床分期的患者发生局部疾病的可能性较小(P = 0.007),包膜穿透的机会更大(P = 0.04),精囊受累的机会更大(P = 0.004)。结论:我们的数据表明,术前血清PSA,Gleason评分较高和临床分期较高的患者在RARP后有更高的病理分期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号